Financing channel feed – Endpoints News

Financing channel feed

French-Belgian biotech banks €20M to break ground in blood-splattered field of therapeutic cancer vaccines

6 years ago

Boehringer, Novo-backed German biotech banks €11M in liver regeneration push

6 years ago

First Chinese biotech on Nasdaq in two years draws $104M

6 years ago

Frazier closes 12th fund in 30 years, with $617M to bet on cell/gene therapy, Big Pharma spinoffs and more

6 years ago

Takeda hops onto $61M round for CRISPR player synthesizing Cas9 alternatives

6 years ago

UPMC venture arm earmarks $1B investment in life sciences

6 years ago

Gates vets at Adjuvant back Codagenix's software-driven approach to recoding RSV, flu, oncolytic viruses and more

6 years ago

Shooting for $100M IPO, Schrödinger takes the wraps off its five internal drugs and discloses deal details

6 years ago

Biopharma ends decade with near-record investment — but is it going to the right places?

6 years ago

RA Capital, Canaan help infuse $50M into Alta-incubated biotech battling acquired resistance to TKIs

6 years ago

Alexis Borisy has $200M to back a market-based plan aimed at curing America’s drug pricing ‘sickness’

6 years ago

What are biopharma companies hiring CROs for these days? PPD spells it out in bid for $100M IPO

6 years ago

With $110M to add to the bankroll, Generation Bio sets its sights on engineering a revolution in the gene therapy field

6 years ago

Blackstone plots $4.5B+ life sciences fund — and they've already secured the bulk of it

6 years ago

DCVC Bio, 5AM back colonizing army of genetically engineered gut bacteria with $33M

6 years ago

Primed for attack: Vaccine tech maker gets $11M shot to battle infectious disease

6 years ago

Shreds of Tregs: French biotech wins Medicxi backing to kill the rogue immunosuppressive agent to fight cancer

6 years ago

WuXi-backed Adagene scores $69M round led by General Atlantic to push antibodies where Bristol-Myers struggled

6 years ago

Aim for the brain: RA Capital bets on Colorado biotech to reformulate epilepsy drug for refractory patients

6 years ago

A for augmented: Cambridge AI company out to capture biomedical knowledge gets $60M from Mayo, Silicon Valley VC

6 years ago

Fish oil pill for NASH? Dutch biotech scores $40M injection to make a mark in the bustling field

6 years ago

SpaceX investor backs Toronto AI upstart's journey into the 'dark region' of genetic diseases

6 years ago

MPM backs new biotech in the hunt for non-opioid painkiller

6 years ago

Fresh from $94.5M crossover round, Frazier-groomed dermatology biotech shoots for $100M IPO

6 years ago

First page Previous page 104 105 106107108 109 110 Next page Last page